<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0005110'>Atrial fibrillation</z:hpo> is a common <z:hpo ids='HP_0011675'>cardiac arrhythmia</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Management of <z:hpo ids='HP_0005110'>atrial fibrillation</z:hpo> should focus on prevention of thromboembolic complications and the treatment of <z:hpo ids='HP_0011675'>arrhythmia</z:hpo> related symptoms </plain></SENT>
<SENT sid="2" pm="."><plain>This article will discuss <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> therapy in nonvalvular <z:hpo ids='HP_0005110'>atrial fibrillation</z:hpo> and review results from several controlled trials </plain></SENT>
</text></document>